Palisade Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.3M | Buy |
240,619
+8,423
| +4% | +$1.18M | 0.94% | 29 |
|
|
2025
Q4 | $38M | Sell |
232,196
-29,602
| -11% | -$4.64M | 1.13% | 14 |
|
|
2025
Q3 | $35M | Sell |
261,798
-3,390
| -1% | -$412K | 0.95% | 22 |
|
|
2025
Q2 | $33M | Sell |
265,188
-8,309
| -3% | -$1.06M | 0.93% | 30 |
|
|
2025
Q1 | $34.8M | Buy |
273,497
+13,388
| +5% | +$2.06M | 1% | 22 |
|
|
2024
Q4 | $37.4M | Buy |
260,109
+14,654
| +6% | +$2.1M | 1% | 23 |
|
|
2024
Q3 | $36.5M | Buy |
245,455
+1,590
| +0.7% | +$228K | 0.97% | 27 |
|
|
2024
Q2 | $30.7M | Buy |
243,865
+59,148
| +32% | +$9.27M | 0.84% | 38 |
|
|
2024
Q1 | $34M | Sell |
184,717
-43,933
| -19% | -$8.37M | 0.9% | 33 |
|
|
2023
Q4 | $41.1M | Sell |
228,650
-20,733
| -8% | -$3.23M | 1.09% | 15 |
|
|
2023
Q3 | $39.7M | Buy |
249,383
+4,087
| +2% | +$668K | 1.11% | 19 |
|
|
2023
Q2 | $34.7M | Buy |
245,296
+9,972
| +4% | +$1.6M | 0.92% | 25 |
|
|
2023
Q1 | $39.6M | Buy |
235,324
+5,230
| +2% | +$933K | 1.07% | 17 |
|
|
2022
Q4 | $39M | Sell |
230,094
-4,705
| -2% | -$853K | 1.05% | 17 |
|
|
2022
Q3 | $43.9M | Buy |
234,799
+117
| +0% | +$24.7K | 1.25% | 8 |
|
|
2022
Q2 | $38.1M | Buy |
234,682
+3,432
| +1% | +$543K | 1.03% | 15 |
|
|
2022
Q1 | $43.5M | Sell |
231,250
-17,018
| -7% | -$3.23M | 1% | 13 |
|
|
2021
Q4 | $65.8M | Sell |
248,268
-44,332
| -15% | -$11.9M | 1.33% | 6 |
|
|
2021
Q3 | $84.6M | Buy |
292,600
+4,873
| +2% | +$1.25M | 1.85% | 1 |
|
|
2021
Q2 | $57.4M | Sell |
287,727
-5,988
| -2% | -$1.16M | 1.3% | 4 |
|
|
2021
Q1 | $57.1M | Buy |
293,715
+10,997
| +4% | +$2.25M | 1.34% | 7 |
|
|
2020
Q4 | $54.2M | Sell |
282,718
-58,479
| -17% | -$10.6M | 1.39% | 4 |
|
|
2020
Q3 | $50.3M | Buy |
341,197
+13,271
| +4% | +$1.9M | 1.49% | 4 |
|
|
2020
Q2 | $40.5M | Buy |
327,926
+1,187
| +0.4% | +$140K | 1.29% | 5 |
|
|
2020
Q1 | $31.5M | Sell |
326,739
-72,757
| -18% | -$7.02M | 1.12% | 6 |
|
|
2019
Q4 | $37M | Sell |
399,496
-766
| -0.2% | -$64.3K | 1.05% | 11 |
|
|
2019
Q3 | $30.7M | Sell |
400,262
-21,529
| -5% | -$1.88M | 0.94% | 22 |
|
|
2019
Q2 | $36.3M | Sell |
421,791
-79,077
| -16% | -$5.39M | 1.12% | 9 |
|
|
2019
Q1 | $29.6M | Buy |
500,868
+23,174
| +5% | +$1.33M | 0.95% | 13 |
|
|
2018
Q4 | $25.2M | Sell |
477,694
-285,763
| -37% | -$16.8M | 0.92% | 16 |
|
|
2018
Q3 | $42.3M | Sell |
763,457
-147,247
| -16% | -$7.59M | 1.17% | 6 |
|
|
2018
Q2 | $42.8M | Buy |
910,704
+148,660
| +20% | +$6.12M | 1.24% | 5 |
|
|
2018
Q1 | $27.6M | Buy |
762,044
+24,900
| +3% | +$876K | 0.93% | 20 |
|
|
2017
Q4 | $26.7M | Buy |
737,144
+78,165
| +12% | +$2.83M | 0.91% | 21 |
|
|
2017
Q3 | $25.3M | Buy |
658,979
+28,646
| +5% | +$1.2M | 0.9% | 23 |
|
|
2017
Q2 | $26.1M | Sell |
630,333
-28,066
| -4% | -$1.07M | 0.98% | 11 |
|
|
2017
Q1 | $23.2M | Sell |
658,399
-6,877
| -1% | -$218K | 0.89% | 20 |
|
|
2016
Q4 | $20.5M | Sell |
665,276
-55,032
| -8% | -$1.7M | 0.77% | 29 |
|
|
2016
Q3 | $21.7M | Sell |
720,308
-10
| -0% | -$302 | 0.77% | 22 |
|
|
2016
Q2 | $19.7M | Buy |
720,318
+45,972
| +7% | +$1.18M | 0.72% | 28 |
|
|
2016
Q1 | $18.1M | Buy |
674,346
+176,514
| +35% | +$4.32M | 0.59% | 35 |
|
|
2015
Q4 | $14.1M | Buy |
497,832
+73,690
| +17% | +$2.13M | 0.46% | 54 |
|
|
2015
Q3 | $11.8M | Buy |
424,142
+46,111
| +12% | +$1.67M | 0.35% | 85 |
|
|
2015
Q2 | $15.6M | Buy |
378,031
+5,320
| +1% | +$195K | 0.4% | 70 |
|
|
2015
Q1 | $11.3M | Buy |
+372,711
| New | +$9.67M | 0.28% | 128 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
Palisade Capital Management's RGEN Position: Q1 2026 in Review
Palisade Capital Management increased its Repligen (RGEN) stake by 3.6% in Q1 2026, buying an estimated $1.18M and bringing the position to 240,619 shares worth $28.3M. The position accounts for 0.94% of the portfolio, ranked #29.
Palisade Capital Management first reported a position in RGEN in Q1 2015 and has held it in 45 quarters since. The position peaked at $84.6M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Palisade Capital Management held 240,619 shares of Repligen worth $28.3M as of Q1 2026.
- Palisade Capital Management bought 8,423 Repligen shares in Q1 2026, an estimated $1.18M.
- Repligen made up 0.94% of Palisade Capital Management's portfolio in Q1 2026, its #29 holding.
- Palisade Capital Management first reported a position in Repligen in Q1 2015 and has held it in 45 quarters since.
- Palisade Capital Management's Repligen position peaked at $84.6M in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Palisade Capital Management's 13F filing for Q1 2026, filed 15 May 2026.